Irisin: A potentially candidate marker for myocardial infarction

dc.contributor.authorKuloglu, Tuncay
dc.contributor.authorAydin, Suna
dc.contributor.authorEren, Mehmet Nesimi
dc.contributor.authorYilmaz, Musa
dc.contributor.authorSahin, Ibrahim
dc.contributor.authorKalayci, Mehmet
dc.contributor.authorAydin, Suleyman
dc.date.accessioned2026-08-12T17:32:07Z
dc.date.issued2014
dc.departmentFırat Üniversitesi
dc.description.abstractMyocardial infarction (MI) causes energy depletion through imbalance between coronary blood supply and myocardial demand. Irisin produced by the heart reduces ATP production by increasing heat generation. Energy depletion affects irisin concentration in circulation and cardiac tissues, suggesting an association with MI. We examined: (1) irisin expression immunohistochemically in rat heart, skeletal muscle, kidney and liver in isoproterenol (ISO)-induced MI, and (2) serum irisin concentration by ELISA. Rats were randomly allocated into 6 groups (n=6), (i) control, (ii) ISO (1 h), (iii) ISO (2 h), (iv) ISO (4 h), (v) ISO (6 h), and (vi) ISO (24 h), 200 mg ISO in each case. Rats were decapitated and the blood and tissues collected for irisin analysis. Blood was centrifuged at 1792 g for 5 min. Tissues were washed with saline and fixed in 10% formalin for histology. Serum irisin levels gradually decreased from 1 h to 24h in MI rats compared with controls, the minimum being at 2 h, increasing again after 6 h. Cardiac muscle cells, glomerular, peritubular renal cortical interstitial cells, hepatocytes and liver sinusoidal cells and perimysium, endomysium and nucleoi of skeletal muscle were irisin positive, but its synthesis decreased 1-4 h after MI. At all time-points, irisin increased near myocardial connective tissue, with production in skeletal muscle, liver and kidney recovering after 6 h, although slower than controls. Unique insight into the pathogenesis of MI is shown, and the gradually decrease of serum irisin might be a diagnostic marker for MI. (C) 2014 Elsevier Inc. All rights reserved.
dc.identifier.doi10.1016/j.peptides.2014.02.008
dc.identifier.endpage91
dc.identifier.issn0196-9781
dc.identifier.issn1873-5169
dc.identifier.orcid0000-0003-0903-3522
dc.identifier.orcid0000-0002-4671-9315
dc.identifier.orcid0000-0001-9557-678X
dc.identifier.orcid0000-0001-9874-3838
dc.identifier.orcid0000-0001-8880-4932
dc.identifier.pmid24576483
dc.identifier.scopus2-s2.0-84896140402
dc.identifier.scopusqualityQ2
dc.identifier.startpage85
dc.identifier.urihttps://doi.org/10.1016/j.peptides.2014.02.008
dc.identifier.urihttps://hdl.handle.net/11508/56522
dc.identifier.volume55
dc.identifier.wosWOS:000335503900012
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofPeptides
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectIrisin
dc.subjectMyocardial infarction
dc.subjectIsoproterenol
dc.subjectHeart
dc.subjectSkeletal muscle
dc.subjectKidneys
dc.titleIrisin: A potentially candidate marker for myocardial infarction
dc.typeArticle

Dosyalar